Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-000562-21Phase 2Completed
Phase 2, single-arm trial of acetyl-DL-leucine in balance disorder and vestibulopathy, sponsored by Pierre Fabre Laboratories. Primary endpoint: Subjective dizziness complaints. Started Jul 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-000562-21.